首页 > 最新文献

Korean journal of hepato-biliary-pancreatic surgery最新文献

英文 中文
In vitro immune cell monitoring as a guide for long-term immunosuppression in adult liver transplant recipients 体外免疫细胞监测对成人肝移植受者长期免疫抑制的指导作用
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.139
Eun-Kyoung Jwa, Shin Hwang, Y. Kwon, Nayoung Kim, G. Song, D. Jung, C. Ahn, E. Tak, D. Moon, Ki‐Hun Kim, T. Ha, G. Park, Sung‐Gyu Lee
Backgrounds/Aims We evaluated the clinical usability of immune cell monitoring in adult liver transplantation (LT) recipients. Methods This study was composed of two parts as using calcineurin phosphatase (CNP) activity assay and ImmuKnow assay independently as in vitro monitoring tools of immune cell function in adult LT recipients. Results There was a rough correlation between CNP activity and tacrolimus concentration in 33 patients. This association was evident in patients who were only administered tacrolimus, but disappeared after the co-administration of mycophenolate. In 118 healthy individuals, the mean proportion of helper T-cells was 37.4±8.1%. According to ImmuKnow assay, their immune responses were strong in 12 patients (10.2%), moderate in 92 patients (78.0%), and low in 14 patients (11.9%). In 85 patients waiting for LT, there was a rough correlation between the ImmuKnow ATP level and age. Their immune responses were strong in 0 patients (0%), moderate in 8 patients (9.4%), and low in 77 patients (90.6%). There was a difference in the ImmuKnow ATP levels between healthy individuals and patients with liver disease. In 137 LT recipients, there was no correlation between the ImmuKnow ATP levels and tacrolimus concentration. This trend did not change after grouping the patients according to co-administration with mycophenolate. Eight recipients experienced acute rejection, but none showed strong immune response. Conclusions We think that both CNP activity assay and ImmuKnow assay are too limited to objectively determine the level of immunosuppression. Further studies should be performed to identify other methods for immune function monitoring.
背景/目的我们评估了免疫细胞监测在成人肝移植(LT)受者中的临床可用性。方法采用钙调磷酸酶(calcalineurin phosphatase, CNP)活性测定法和immunoknow测定法分别作为成人肝移植受体免疫细胞功能的体外监测工具。结果33例患者CNP活性与他克莫司浓度有粗略的相关性。这种关联在仅使用他克莫司的患者中很明显,但在联合使用霉酚酸酯后消失。118名健康人的平均辅助性t细胞比例为37.4±8.1%。免疫检测结果显示,12例(10.2%)患者免疫反应强,92例(78.0%)患者免疫反应中等,14例(11.9%)患者免疫反应低。在85例等待肝移植的患者中,ImmuKnow ATP水平与年龄有粗略的相关性。免疫应答强者0例(0%),中等者8例(9.4%),低者77例(90.6%)。在健康个体和肝病患者之间,immunknow ATP水平存在差异。在137例LT受体中,ImmuKnow ATP水平与他克莫司浓度之间没有相关性。根据与霉酚酸酯共同给药对患者进行分组后,这一趋势没有改变。8名受者经历了急性排斥反应,但没有人表现出强烈的免疫反应。结论CNP活性测定和immunoknow测定均存在局限性,无法客观判断免疫抑制水平。应该进行进一步的研究以确定免疫功能监测的其他方法。
{"title":"In vitro immune cell monitoring as a guide for long-term immunosuppression in adult liver transplant recipients","authors":"Eun-Kyoung Jwa, Shin Hwang, Y. Kwon, Nayoung Kim, G. Song, D. Jung, C. Ahn, E. Tak, D. Moon, Ki‐Hun Kim, T. Ha, G. Park, Sung‐Gyu Lee","doi":"10.14701/kjhbps.2015.19.4.139","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.139","url":null,"abstract":"Backgrounds/Aims We evaluated the clinical usability of immune cell monitoring in adult liver transplantation (LT) recipients. Methods This study was composed of two parts as using calcineurin phosphatase (CNP) activity assay and ImmuKnow assay independently as in vitro monitoring tools of immune cell function in adult LT recipients. Results There was a rough correlation between CNP activity and tacrolimus concentration in 33 patients. This association was evident in patients who were only administered tacrolimus, but disappeared after the co-administration of mycophenolate. In 118 healthy individuals, the mean proportion of helper T-cells was 37.4±8.1%. According to ImmuKnow assay, their immune responses were strong in 12 patients (10.2%), moderate in 92 patients (78.0%), and low in 14 patients (11.9%). In 85 patients waiting for LT, there was a rough correlation between the ImmuKnow ATP level and age. Their immune responses were strong in 0 patients (0%), moderate in 8 patients (9.4%), and low in 77 patients (90.6%). There was a difference in the ImmuKnow ATP levels between healthy individuals and patients with liver disease. In 137 LT recipients, there was no correlation between the ImmuKnow ATP levels and tacrolimus concentration. This trend did not change after grouping the patients according to co-administration with mycophenolate. Eight recipients experienced acute rejection, but none showed strong immune response. Conclusions We think that both CNP activity assay and ImmuKnow assay are too limited to objectively determine the level of immunosuppression. Further studies should be performed to identify other methods for immune function monitoring.","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"139 - 148"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.139","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66890153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Clinical outcomes in surgical and non-surgical management of hepatic portal venous gas 肝门静脉气体手术与非手术治疗的临床效果
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.181
Soo-kyung Yoo, Jong-hoon Park, S. Kwon
Backgrounds/Aims Hepatic portal venous gas (HPVG) is a rare condition, with poor prognosis and a mortality rate of up to 75%. Indications for surgical and non-surgical management of HPVG including associated complications and mortality remain to be clarified. Methods From January 2008 to December 2014, 18 patients with HPVG diagnosed through abdominal computed tomography (CT) imaging were retrospectively identified. Clinical symptoms, laboratory data, underlying diseases, treatment, and mortality rate were analyzed. Patients were classified into 2 groups: surgical management recommended (SR, n=10) and conservative management (CM, n=8). The SR group was further subdivided into patients who underwent surgical management (SM-SR, n=5) and those who were managed conservatively (NS-SR, n=5). Results Conditions underlying HPVG included mesenteric ischemia (38.9%), intestinal obstruction (22.2%), enteritis (22.2%), duodenal ulcer perforation (5.6%), necrotizing pancreatitis (5.6%), and diverticulitis (5.6%). In terms of mortality, 2 patients (40%) died in the SM-SR group, 1 (12.5%) in the CM group, and 100% in the NS-SR group. Higher scores from Acute Physiology and Chronic Health Evaluation (APACHE) II predicted the mortality rates of the NS-SR and CM groups. Conclusions Identification of HPVG requires careful consideration for surgical management. If surgical management is indicated, prompt laparotomy should be performed. However, even in the non-surgical management condition, aggressive laparotomy can improve survival rates for patients with high APACHE II scores.
背景/目的肝门静脉气体(HPVG)是一种罕见的疾病,预后差,死亡率高达75%。手术和非手术治疗HPVG的适应症,包括相关并发症和死亡率仍有待澄清。方法回顾性分析2008年1月至2014年12月18例经腹部CT诊断为HPVG的患者。分析临床症状、实验室数据、基础疾病、治疗和死亡率。患者分为两组:推荐手术治疗组(SR, n=10)和保守治疗组(CM, n=8)。SR组进一步细分为手术治疗组(SM-SR, n=5)和保守治疗组(NS-SR, n=5)。结果HPVG的病因包括肠系膜缺血(38.9%)、肠梗阻(22.2%)、肠炎(22.2%)、十二指肠溃疡穿孔(5.6%)、坏死性胰腺炎(5.6%)和憩室炎(5.6%)。在死亡率方面,SM-SR组死亡2例(40%),CM组死亡1例(12.5%),NS-SR组死亡100%。急性生理和慢性健康评估(APACHE) II得分越高,预测NS-SR组和CM组的死亡率。结论HPVG的鉴别需要慎重考虑手术治疗。如果需要手术治疗,应及时进行剖腹手术。然而,即使在非手术治疗条件下,积极剖腹手术也可以提高高APACHE II评分患者的生存率。
{"title":"Clinical outcomes in surgical and non-surgical management of hepatic portal venous gas","authors":"Soo-kyung Yoo, Jong-hoon Park, S. Kwon","doi":"10.14701/kjhbps.2015.19.4.181","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.181","url":null,"abstract":"Backgrounds/Aims Hepatic portal venous gas (HPVG) is a rare condition, with poor prognosis and a mortality rate of up to 75%. Indications for surgical and non-surgical management of HPVG including associated complications and mortality remain to be clarified. Methods From January 2008 to December 2014, 18 patients with HPVG diagnosed through abdominal computed tomography (CT) imaging were retrospectively identified. Clinical symptoms, laboratory data, underlying diseases, treatment, and mortality rate were analyzed. Patients were classified into 2 groups: surgical management recommended (SR, n=10) and conservative management (CM, n=8). The SR group was further subdivided into patients who underwent surgical management (SM-SR, n=5) and those who were managed conservatively (NS-SR, n=5). Results Conditions underlying HPVG included mesenteric ischemia (38.9%), intestinal obstruction (22.2%), enteritis (22.2%), duodenal ulcer perforation (5.6%), necrotizing pancreatitis (5.6%), and diverticulitis (5.6%). In terms of mortality, 2 patients (40%) died in the SM-SR group, 1 (12.5%) in the CM group, and 100% in the NS-SR group. Higher scores from Acute Physiology and Chronic Health Evaluation (APACHE) II predicted the mortality rates of the NS-SR and CM groups. Conclusions Identification of HPVG requires careful consideration for surgical management. If surgical management is indicated, prompt laparotomy should be performed. However, even in the non-surgical management condition, aggressive laparotomy can improve survival rates for patients with high APACHE II scores.","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"181 - 187"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.181","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66889992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Comparison of survival outcomes after anatomical resection and non-anatomical resection in patients with hepatocellular carcinoma 肝细胞癌解剖切除与非解剖切除的生存结果比较
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.161
Seheon Kim, Seokwhan Kim, I. Song, Kwang-Sik Chun
Backgrounds/Aims Liver resection is a curative procedure performed worldwide for hepatocellular carcinoma (HCC). Deciding on the appropriate resection range for postoperative hepatic function preservation is an important surgical consideration. This study compares survival outcomes of HCC patients who underwent anatomical or non-anatomical resection, to determine which offers the best clinical survival benefit. Methods One hundred and thirty-one patients underwent liver resection with HCC, between January 2007 and February 2015, and were divided into two groups: those who underwent anatomical liver resection (n=88) and those who underwent non-anatomical liver resection (n=43). Kaplan-Meier survival analysis and Cox regressions were used to compare the disease-free survival (DFS) and overall survival (OS) rates between the groups. Results The mean follow-up periods were 27 and 40 months in the anatomical and non-anatomical groups, respectively (p=0.229). The 3- and 5-year DFS rates were 70% and 60% in the anatomical group and 62% and 48% in the non-anatomical group, respectively. The 3 and 5-year OS rates were 94% and 78% in the anatomical group, and 86% and 80% in the non-anatomical group, respectively. The anatomical group tended to show better outcomes, but the findings were not significant. However, a relative risk of OS between the anatomical and non-anatomical group was 0.234 (95% CI, 0.061-0.896; p=0.034), which is statistically significant. Conclusions Although statistical significance was not detected in survival curves, anatomical resection showed better results. In this respect, anatomical resection is more likely to perform in HCC patients with preserve liver function than non-anatomical resection.
背景/目的肝切除术是世界范围内治疗肝细胞癌(HCC)的一种方法。选择合适的切除范围以保留术后肝功能是外科手术的重要考虑因素。本研究比较了肝细胞癌患者解剖切除和非解剖切除的生存结果,以确定哪一种能提供最好的临床生存益处。方法2007年1月至2015年2月,131例肝癌患者行肝切除术,分为解剖性肝切除术组(88例)和非解剖性肝切除术组(43例)。采用Kaplan-Meier生存分析和Cox回归比较两组无病生存(DFS)和总生存(OS)率。结果解剖组和非解剖组的平均随访时间分别为27个月和40个月(p=0.229)。解剖组3年和5年的DFS分别为70%和60%,非解剖组为62%和48%。解剖组3年和5年OS分别为94%和78%,非解剖组为86%和80%。解剖组倾向于表现出更好的结果,但结果并不显著。然而,解剖组和非解剖组发生OS的相对风险为0.234 (95% CI, 0.061-0.896;P =0.034),差异有统计学意义。结论虽然生存曲线无统计学意义,但解剖切除效果较好。在这方面,对于保留肝功能的HCC患者,解剖切除比非解剖切除更有可能进行。
{"title":"Comparison of survival outcomes after anatomical resection and non-anatomical resection in patients with hepatocellular carcinoma","authors":"Seheon Kim, Seokwhan Kim, I. Song, Kwang-Sik Chun","doi":"10.14701/kjhbps.2015.19.4.161","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.161","url":null,"abstract":"Backgrounds/Aims Liver resection is a curative procedure performed worldwide for hepatocellular carcinoma (HCC). Deciding on the appropriate resection range for postoperative hepatic function preservation is an important surgical consideration. This study compares survival outcomes of HCC patients who underwent anatomical or non-anatomical resection, to determine which offers the best clinical survival benefit. Methods One hundred and thirty-one patients underwent liver resection with HCC, between January 2007 and February 2015, and were divided into two groups: those who underwent anatomical liver resection (n=88) and those who underwent non-anatomical liver resection (n=43). Kaplan-Meier survival analysis and Cox regressions were used to compare the disease-free survival (DFS) and overall survival (OS) rates between the groups. Results The mean follow-up periods were 27 and 40 months in the anatomical and non-anatomical groups, respectively (p=0.229). The 3- and 5-year DFS rates were 70% and 60% in the anatomical group and 62% and 48% in the non-anatomical group, respectively. The 3 and 5-year OS rates were 94% and 78% in the anatomical group, and 86% and 80% in the non-anatomical group, respectively. The anatomical group tended to show better outcomes, but the findings were not significant. However, a relative risk of OS between the anatomical and non-anatomical group was 0.234 (95% CI, 0.061-0.896; p=0.034), which is statistically significant. Conclusions Although statistical significance was not detected in survival curves, anatomical resection showed better results. In this respect, anatomical resection is more likely to perform in HCC patients with preserve liver function than non-anatomical resection.","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"161 - 166"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.161","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66890337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Erratum: Therapeutic induction of hepatic atrophy for isolated injury of the right anterior sectoral duct following laparoscopic cholecystectomy 误注:腹腔镜胆囊切除术后右前段胆管孤立性损伤的肝萎缩诱导治疗
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.194
Shin Hwang, Sam-Youl Yoon, Sung-Won Jung, J. Namgoong, G. Park, D. Gwon, Sung‐Gyu Lee
[This corrects the article on p. 189 in vol. 15, PMID: 26421038.].
[这更正了第15卷第189页的文章,PMID: 26421038]。
{"title":"Erratum: Therapeutic induction of hepatic atrophy for isolated injury of the right anterior sectoral duct following laparoscopic cholecystectomy","authors":"Shin Hwang, Sam-Youl Yoon, Sung-Won Jung, J. Namgoong, G. Park, D. Gwon, Sung‐Gyu Lee","doi":"10.14701/kjhbps.2015.19.4.194","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.194","url":null,"abstract":"[This corrects the article on p. 189 in vol. 15, PMID: 26421038.].","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"194 - 194"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.194","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66890115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatigue and related factors after liver transplantation 肝移植术后疲劳及相关因素分析
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.149
K. Hong, Hyeyoung Kim, Jeong‐Moo Lee, Kwang-Wonng Lee, N. Yi, Hae Won Lee, Y. Choi, S. Suh, S. Hong, K. Yoon, Hyo-Sin Kim, K. Suh
Backgrounds/Aims Fatigue is common in chronic hepatitis and end-stage liver disease. However, little is known about fatigue after liver transplantation (LT). We therefore evaluated the prevalence, severity, and related factors of fatigue after LT. Methods We retrospectively reviewed adult recipients who responded to our survey at outpatient clinics between April and May 2013. Fatigue and its severity were assessed using a questionnaire with the Fatigue Severity Scale (FSS). We defined fatigue as FSS of 4.0 or more and severe fatigue as FSS of 5.1 or more. The related factors including hepatocellular carcinoma and complications were analyzed. Results A total of 93 patients were included in this study. The mean age was 54.9 (19-76) years and two-thirds were men (67.7%). Living donor LT was 77.4%. Hepatitis B related liver disease was the main underlying disease (77.4%), with hepatocellular carcinoma accompanied in 33.3%. The mean follow-up period was 66.8±43.2 (2-171) months. The mean FFS was 2.83±1.48 (1.0-6.7) overall and 5.10±0.82 (4.0-6.7) in the fatigue group. Of the 93 adult patients, fatigue was presented in 20 patients (21.5%). Among these, 9 patients (45.0%) showed severe fatigue. Even though post-LT complications tended to be greater in the fatigue group (50.0% vs. 30.1% in the non-fatigue group, p=0.098), there were no significant related factors of fatigue after LT, including hepatocellular carcinoma and major complication. Conclusions Fatigue is present in a considerable portion of recipients after LT, and almost half of them have severe fatigue. Further efforts are needed to decrease fatigue in LT recipients.
背景/目的疲劳在慢性肝炎和终末期肝病中很常见。然而,人们对肝移植后的疲劳知之甚少。因此,我们评估了lt后疲劳的患病率、严重程度和相关因素。方法回顾性分析了2013年4月至5月在门诊诊所接受调查的成年接受者。使用疲劳严重程度量表(FSS)进行疲劳及其严重程度的评估。我们将疲劳定义为FSS为4.0或更高,严重疲劳定义为FSS为5.1或更高。分析肝细胞癌及并发症等相关因素。结果本研究共纳入93例患者。平均年龄为54.9岁(19-76岁),男性占三分之二(67.7%)。活体供者LT为77.4%。乙肝相关肝病为主要基础疾病(77.4%),肝细胞癌为33.3%。平均随访66.8±43.2(2-171)个月。疲劳组平均FFS为2.83±1.48(1.0 ~ 6.7),疲劳组平均FFS为5.10±0.82(4.0 ~ 6.7)。93例成人患者中有20例(21.5%)出现疲劳。其中有9例(45.0%)表现为重度疲劳。尽管疲劳组肝移植后的并发症往往更大(50.0% vs. 30.1%, p=0.098),但肝移植后的疲劳没有明显的相关因素,包括肝细胞癌和主要并发症。结论:相当一部分移植后受者存在疲劳,其中近一半有严重的疲劳。需要进一步努力减少肝移植受者的疲劳。
{"title":"Fatigue and related factors after liver transplantation","authors":"K. Hong, Hyeyoung Kim, Jeong‐Moo Lee, Kwang-Wonng Lee, N. Yi, Hae Won Lee, Y. Choi, S. Suh, S. Hong, K. Yoon, Hyo-Sin Kim, K. Suh","doi":"10.14701/kjhbps.2015.19.4.149","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.149","url":null,"abstract":"Backgrounds/Aims Fatigue is common in chronic hepatitis and end-stage liver disease. However, little is known about fatigue after liver transplantation (LT). We therefore evaluated the prevalence, severity, and related factors of fatigue after LT. Methods We retrospectively reviewed adult recipients who responded to our survey at outpatient clinics between April and May 2013. Fatigue and its severity were assessed using a questionnaire with the Fatigue Severity Scale (FSS). We defined fatigue as FSS of 4.0 or more and severe fatigue as FSS of 5.1 or more. The related factors including hepatocellular carcinoma and complications were analyzed. Results A total of 93 patients were included in this study. The mean age was 54.9 (19-76) years and two-thirds were men (67.7%). Living donor LT was 77.4%. Hepatitis B related liver disease was the main underlying disease (77.4%), with hepatocellular carcinoma accompanied in 33.3%. The mean follow-up period was 66.8±43.2 (2-171) months. The mean FFS was 2.83±1.48 (1.0-6.7) overall and 5.10±0.82 (4.0-6.7) in the fatigue group. Of the 93 adult patients, fatigue was presented in 20 patients (21.5%). Among these, 9 patients (45.0%) showed severe fatigue. Even though post-LT complications tended to be greater in the fatigue group (50.0% vs. 30.1% in the non-fatigue group, p=0.098), there were no significant related factors of fatigue after LT, including hepatocellular carcinoma and major complication. Conclusions Fatigue is present in a considerable portion of recipients after LT, and almost half of them have severe fatigue. Further efforts are needed to decrease fatigue in LT recipients.","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"149 - 153"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.149","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66890205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for small hepatocellular carcinoma: short-term result 术中射频消融与非解剖性肝切除术治疗小肝癌的近期疗效比较分析
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.173
Y. Yune, Seokwhan Kim, I. Song, Kwang-Sik Chun
Backgrounds/Aims To compare the clinical outcomes of intraoperative radiofrequency ablation (RFA) and non-anatomical hepatic resection (NAHR) for small hepatocellular carcinoma (HCC). Methods From February 2007 to January 2015, clinical outcomes of thirty four patients with HCC receiving RFA or NAHR were compared, retrospectively. Results There was no difference of patient and tumor characteristic between the two groups that received RFA or NAHR. The 1, 2, and 3-year recurrence rates following RFA were 32.2%, 32.2% and 59.3% respectively, and 6.7%, 33.3% and 33.3% following NAHR respectively (p=0.287). The 1, 2 and 3-year overall survival (OS) rates following RFA were 100%, 88.9% and 76.2% respectively, and 100%, 85.6% and 85.6%, respectively, following NAHR (p=0.869). We did not find a definite statistical difference in recurrence rate and OS rate between the two groups. In the multivariate analysis, number of tumor was an independent prognostic factor for recurrence and albumin was an independent prognostic factor for OS. Conclusions We recommend non-anatomical hepatic resection rather than intraoperative RFA in small sized HCC, due to a higher recurrence rate in intraoperative RFA. Intraoperative RFA was inferior to non-anatomical hepatic resection in terms of recurrence rate. We need to select the optimal treatment considering liver function and possibility of recurrence.
背景/目的比较术中射频消融(RFA)与非解剖性肝切除术(NAHR)治疗小肝细胞癌的临床疗效。方法回顾性比较2007年2月至2015年1月34例HCC患者接受RFA或NAHR治疗的临床结果。结果RFA组与NAHR组患者及肿瘤特征无明显差异。RFA术后1、2、3年复发率分别为32.2%、32.2%、59.3%,NAHR术后1、2、3年复发率分别为6.7%、33.3%、33.3% (p=0.287)。RFA术后1、2、3年总生存率分别为100%、88.9%、76.2%,NAHR术后1、2、3年总生存率分别为100%、85.6%、85.6% (p=0.869)。两组的复发率和总生存率没有明显的统计学差异。在多因素分析中,肿瘤数目是复发的独立预后因素,白蛋白是OS的独立预后因素。结论我们推荐非解剖性肝切除术,而不是术中射频消融治疗小肝癌,因为术中射频消融的复发率更高。术中RFA的复发率低于非解剖性肝切除术。我们需要考虑肝功能和复发的可能性来选择最佳的治疗方法。
{"title":"Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for small hepatocellular carcinoma: short-term result","authors":"Y. Yune, Seokwhan Kim, I. Song, Kwang-Sik Chun","doi":"10.14701/kjhbps.2015.19.4.173","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.173","url":null,"abstract":"Backgrounds/Aims To compare the clinical outcomes of intraoperative radiofrequency ablation (RFA) and non-anatomical hepatic resection (NAHR) for small hepatocellular carcinoma (HCC). Methods From February 2007 to January 2015, clinical outcomes of thirty four patients with HCC receiving RFA or NAHR were compared, retrospectively. Results There was no difference of patient and tumor characteristic between the two groups that received RFA or NAHR. The 1, 2, and 3-year recurrence rates following RFA were 32.2%, 32.2% and 59.3% respectively, and 6.7%, 33.3% and 33.3% following NAHR respectively (p=0.287). The 1, 2 and 3-year overall survival (OS) rates following RFA were 100%, 88.9% and 76.2% respectively, and 100%, 85.6% and 85.6%, respectively, following NAHR (p=0.869). We did not find a definite statistical difference in recurrence rate and OS rate between the two groups. In the multivariate analysis, number of tumor was an independent prognostic factor for recurrence and albumin was an independent prognostic factor for OS. Conclusions We recommend non-anatomical hepatic resection rather than intraoperative RFA in small sized HCC, due to a higher recurrence rate in intraoperative RFA. Intraoperative RFA was inferior to non-anatomical hepatic resection in terms of recurrence rate. We need to select the optimal treatment considering liver function and possibility of recurrence.","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"173 - 180"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.173","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66890444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma 胆管侵犯是早期肝细胞癌的独立预后因素
Pub Date : 2015-11-01 DOI: 10.14701/kjhbps.2015.19.4.167
Y. Jang, Kwang-Wonng Lee, Hyeyoung Kim, Jeong‐Moo Lee, N. Yi, K. Suh
Backgrounds/Aims In hepatocellular carcinoma (HCC), bile duct invasion occurs far more rarely than vascular invasion and is not well characterized. In addition, the pathologic finding of bile duct invasion is not considered an independent prognostic factor for HCC following surgery. In this study, we determined the characteristics of HCC with bile duct invasion, and assessed the clinical significance of bile duct invasion. Methods We retrospectively reviewed the medical records of 363 patients who underwent hepatic resection for HCC at Seoul National University Hospital (SNUH) from January 2009 to December 2011. Preoperative, operative, and pathological data were collected. The risk factors for recurrence and survival were analyzed. Subsequently, the patients were divided into 2 groups according to disease stage (American Joint Committee on Cancer/International Union Against Cancer 7th edition): early stage (T1 and 2) and advanced stage (T3 and 4) group; and risk factors in the sub-groups were analyzed. Results Among 363 patients, 13 showed bile duct invasion on pathology. Patients with bile duct invasion had higher preoperative total bilirubin levels, greater microvascular invasion, and a higher death rate than those without bile duct invasion. In multivariate analysis, bile duct invasion was not an independent prognostic factor for survival for the entire cohort, but, was an independent prognostic factor for early stage. Conclusions Bile duct invasion accompanied microvascular invasion in most cases, and could be used as an independent prognostic factor for survival especially in early stage HCC (T1 and T2).
背景/目的在肝细胞癌(HCC)中,胆管侵犯远比血管侵犯少得多,并且没有很好的特征。此外,胆管侵犯的病理表现不被认为是HCC术后的独立预后因素。在本研究中,我们确定HCC合并胆管侵犯的特征,并评估胆管侵犯的临床意义。方法回顾性分析2009年1月至2011年12月在首尔国立大学医院(SNUH)行肝切除术的363例肝癌患者的病历。收集术前、手术及病理资料。分析复发和生存的危险因素。随后,根据疾病分期将患者分为2组(美国癌症联合委员会/国际抗癌联盟第7版):早期(T1和2)和晚期(T3和4)组;并分析各亚组的危险因素。结果363例患者中,13例病理表现为胆管侵犯。胆管侵犯患者术前总胆红素水平较高,微血管侵犯更大,死亡率高于无胆管侵犯患者。在多变量分析中,胆管侵犯不是整个队列生存的独立预后因素,但在早期是一个独立的预后因素。结论胆管侵犯多伴微血管侵犯,可作为独立的预后因素,尤其是早期肝癌(T1和T2)。
{"title":"Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma","authors":"Y. Jang, Kwang-Wonng Lee, Hyeyoung Kim, Jeong‐Moo Lee, N. Yi, K. Suh","doi":"10.14701/kjhbps.2015.19.4.167","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.4.167","url":null,"abstract":"Backgrounds/Aims In hepatocellular carcinoma (HCC), bile duct invasion occurs far more rarely than vascular invasion and is not well characterized. In addition, the pathologic finding of bile duct invasion is not considered an independent prognostic factor for HCC following surgery. In this study, we determined the characteristics of HCC with bile duct invasion, and assessed the clinical significance of bile duct invasion. Methods We retrospectively reviewed the medical records of 363 patients who underwent hepatic resection for HCC at Seoul National University Hospital (SNUH) from January 2009 to December 2011. Preoperative, operative, and pathological data were collected. The risk factors for recurrence and survival were analyzed. Subsequently, the patients were divided into 2 groups according to disease stage (American Joint Committee on Cancer/International Union Against Cancer 7th edition): early stage (T1 and 2) and advanced stage (T3 and 4) group; and risk factors in the sub-groups were analyzed. Results Among 363 patients, 13 showed bile duct invasion on pathology. Patients with bile duct invasion had higher preoperative total bilirubin levels, greater microvascular invasion, and a higher death rate than those without bile duct invasion. In multivariate analysis, bile duct invasion was not an independent prognostic factor for survival for the entire cohort, but, was an independent prognostic factor for early stage. Conclusions Bile duct invasion accompanied microvascular invasion in most cases, and could be used as an independent prognostic factor for survival especially in early stage HCC (T1 and T2).","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 1","pages":"167 - 172"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.4.167","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66890358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Hepatectomy, combined with intraoperative radiofrequency ablation in patients with multiple hepatocellular carcinomas. 肝切除术联合术中射频消融术治疗多发性肝细胞癌。
Pub Date : 2015-08-01 Epub Date: 2015-08-28 DOI: 10.14701/kjhbps.2015.19.3.98
Seok Joon Lee, Eung-Ho Cho, Ryounggo Kim, Young Han Kim, Chang-Sup Lim, Sang Bum Kim

Backgrounds/aims: We compared the efficacy and safety of a hepatectomy, combined with intraoperative radiofrequency ablation to those of wider extent hepatectomy, alone, in patients with multiple hepatocellular carcinomas (HCCs).

Methods: Between January 2004 and December 2013, 78 patients with multiple HCCs underwent surgery. 25 patients were treated by hepatectomy, combined with intraoperative radiofrequency ablation (RFA) (group A), and 53 underwent hepatectomy only (group B). We retrospectively analyzed medical records to compare the clinical features of these two groups.

Results: Patients in group A had more limited resections (less than 2 segments) than those in group B (p<0.001). Patients in group A also tended to have fewer red blood cell transfusions than those in group B (p=0.060). Liver function- and surgery-related complications occurred only in group B. There were no in-hospital mortalities in both groups. The overall survival and disease-free survival outcomes were not significantly different between groups A and B (p=0.177 and p=0.305, respectively).

Conclusions: Hepatectomy combined with intraoperative RFA could be a safe and effective treatment option for patients with multiple HCCs, comparable to extended hepatectomy alone.

背景/目的:我们比较了在多发性肝细胞癌(hcc)患者中肝切除术联合术中射频消融与单纯大范围肝切除术的疗效和安全性。方法:2004年1月至2013年12月,78例多发性hcc患者接受手术治疗。A组25例行肝切除联合术中射频消融(RFA), B组53例仅行肝切除。我们回顾性分析两组的病历,比较两组的临床特点。结果:与B组相比,A组患者的切除范围更有限(小于2节段)。结论:肝切除术联合术中射频消融术是多发hcc患者安全有效的治疗选择,与单纯扩大肝切除术相当。
{"title":"Hepatectomy, combined with intraoperative radiofrequency ablation in patients with multiple hepatocellular carcinomas.","authors":"Seok Joon Lee,&nbsp;Eung-Ho Cho,&nbsp;Ryounggo Kim,&nbsp;Young Han Kim,&nbsp;Chang-Sup Lim,&nbsp;Sang Bum Kim","doi":"10.14701/kjhbps.2015.19.3.98","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.3.98","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>We compared the efficacy and safety of a hepatectomy, combined with intraoperative radiofrequency ablation to those of wider extent hepatectomy, alone, in patients with multiple hepatocellular carcinomas (HCCs).</p><p><strong>Methods: </strong>Between January 2004 and December 2013, 78 patients with multiple HCCs underwent surgery. 25 patients were treated by hepatectomy, combined with intraoperative radiofrequency ablation (RFA) (group A), and 53 underwent hepatectomy only (group B). We retrospectively analyzed medical records to compare the clinical features of these two groups.</p><p><strong>Results: </strong>Patients in group A had more limited resections (less than 2 segments) than those in group B (p<0.001). Patients in group A also tended to have fewer red blood cell transfusions than those in group B (p=0.060). Liver function- and surgery-related complications occurred only in group B. There were no in-hospital mortalities in both groups. The overall survival and disease-free survival outcomes were not significantly different between groups A and B (p=0.177 and p=0.305, respectively).</p><p><strong>Conclusions: </strong>Hepatectomy combined with intraoperative RFA could be a safe and effective treatment option for patients with multiple HCCs, comparable to extended hepatectomy alone.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 3","pages":"98-102"},"PeriodicalIF":0.0,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.3.98","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34013918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
A case of gallbladder cancer combined with ectopic individual opening of pancreatic and bile ducts to the duodenal bulb. 胆囊癌合并个别胰胆管通往十二指肠球的异位开口1例。
Pub Date : 2015-08-01 Epub Date: 2015-08-28 DOI: 10.14701/kjhbps.2015.19.3.121
Woohyung Lee, Ji-Ho Park, Ju-Yeon Kim, Seung-Jin Kwag, Taejin Park, Sang-Ho Jeong, Young-Tae Ju, Eun-Jung Jung, Young-Joon Lee, Sang-Kyung Choi, Soon-Chan Hong, Chi-Young Jeong

Ectopic opening of the pancreatic and bile ducts (EOPBD) into the duodenal bulb is an extremely rare congenital anomaly with unknown clinical implications. We presented a case of gallbladder cancer with EOPBD into the duodenal bulb. A 57-year-old male was referred to our hospital with intermittent right upper abdominal pain. Endoscopic retrograde cholangiopancreatography and magnetic resonance cholangiopancreatography showed individual EOPBD into the duodenal bulb with no papillary structure, and a focal nodular lesion in the gallbladder. A follow-up abdominal computed tomography scan 9 months later revealed a slight increase in the size of the fundal nodule, which was suspected as gallbladder cancer. An intraoperative frozen biopsy identified the nodular lesion as adenocarcinoma involving the cystic duct, and the patient underwent radical cholecystectomy including bile duct resection with hepaticojejunostomy. EOPBD is an extremely rare condition that can be associated with gallbladder malignancy as well as benign disease. Clinicians should follow up carefully and consider surgical treatment for suspected malignant lesions.

摘要胰胆管异位开口进入十二指肠球部是一种极为罕见的先天性异常,临床意义尚不清楚。我们报告一例胆囊癌伴EOPBD进入十二指肠球部。一名57岁男性因间歇性右上腹部疼痛转诊至我院。内镜逆行胆管造影及磁共振胆管造影显示个例EOPBD进入十二指肠球部,无乳头状结构,胆囊局灶性结节病变。9个月后的腹部计算机断层扫描显示,基底结节的大小略有增加,怀疑为胆囊癌。术中冷冻活检发现结节状病变为累及胆囊管的腺癌,患者行根治性胆囊切除术,包括胆管切除术和肝空肠吻合术。EOPBD是一种极其罕见的疾病,可能与胆囊恶性肿瘤以及良性疾病有关。临床医生应仔细随访,并考虑手术治疗疑似恶性病变。
{"title":"A case of gallbladder cancer combined with ectopic individual opening of pancreatic and bile ducts to the duodenal bulb.","authors":"Woohyung Lee,&nbsp;Ji-Ho Park,&nbsp;Ju-Yeon Kim,&nbsp;Seung-Jin Kwag,&nbsp;Taejin Park,&nbsp;Sang-Ho Jeong,&nbsp;Young-Tae Ju,&nbsp;Eun-Jung Jung,&nbsp;Young-Joon Lee,&nbsp;Sang-Kyung Choi,&nbsp;Soon-Chan Hong,&nbsp;Chi-Young Jeong","doi":"10.14701/kjhbps.2015.19.3.121","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.3.121","url":null,"abstract":"<p><p>Ectopic opening of the pancreatic and bile ducts (EOPBD) into the duodenal bulb is an extremely rare congenital anomaly with unknown clinical implications. We presented a case of gallbladder cancer with EOPBD into the duodenal bulb. A 57-year-old male was referred to our hospital with intermittent right upper abdominal pain. Endoscopic retrograde cholangiopancreatography and magnetic resonance cholangiopancreatography showed individual EOPBD into the duodenal bulb with no papillary structure, and a focal nodular lesion in the gallbladder. A follow-up abdominal computed tomography scan 9 months later revealed a slight increase in the size of the fundal nodule, which was suspected as gallbladder cancer. An intraoperative frozen biopsy identified the nodular lesion as adenocarcinoma involving the cystic duct, and the patient underwent radical cholecystectomy including bile duct resection with hepaticojejunostomy. EOPBD is an extremely rare condition that can be associated with gallbladder malignancy as well as benign disease. Clinicians should follow up carefully and consider surgical treatment for suspected malignant lesions. </p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 3","pages":"121-4"},"PeriodicalIF":0.0,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.3.121","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34079604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison between operative versus non-operative management of traumatic liver injury. 外伤性肝损伤手术与非手术治疗的比较。
Pub Date : 2015-08-01 Epub Date: 2015-08-28 DOI: 10.14701/kjhbps.2015.19.3.103
Ki Bum Park, Dong Do You, Tae Ho Hong, Jung Min Heo, Yong Sung Won

Backgrounds/aims: The aim of this study was to compare operative versus non-operative management of patients with liver injury and to ascertain the differences of the clinical features.

Methods: From April 2000 to July 2012, 191 patients were admitted to Seoul St. Mary's Hospital and St. Vincent's Hospital for liver injuries. Of these, 148 patients were included in this study. All patients were diagnosed using computed tomography (CT). The liver injury was graded in accordance with the American Association for the Surgery of Trauma liver injury scoring scale. Patients were divided into two groups: those who underwent surgery and those treated with non-operative management (NOM). There was a comparison between these two groups concerning the clinical characteristics, grade of liver injury, hemodynamic stability, laboratory findings, and mortality.

Results: According to the 148 patient records evaluated, 108 (72.9%) patients were treated with NOM, and 40 (27.1%) underwent surgery. Patients treated with NOM had significantly fewer severe injuries as rated using the Revised Traumatic Injury Scale, Injury Severity Score, and Glasgow Coma Scale. Grade of liver injury and number of patients with extravasation of contrast dye on CT and hemoperitoneum were higher in the operative group than in the NOM group. There were significant differences between the two groups for: heart rate, respiratory rate, systolic blood pressure, and mean hemoglobin levels at admission and after 4 hours. The operative group experienced a significantly higher mortality than the NOM group.

Conclusions: The results of our study suggest that hemodynamic stability and the following should be considered for deciding the treatment for liver injuries: grade of liver injury, amount of blood loss, and injury scales scores.

背景/目的:本研究的目的是比较肝损伤患者的手术与非手术治疗,并确定临床特征的差异。方法:2000年4月至2012年7月,首尔圣玛丽医院和圣文森特医院共收治191例肝损伤患者。其中,148例患者纳入本研究。所有患者均采用计算机断层扫描(CT)进行诊断。肝损伤按照美国创伤外科协会肝损伤评分标准进行分级。患者分为两组:接受手术治疗和非手术治疗(NOM)。比较两组患者的临床特征、肝损伤程度、血流动力学稳定性、实验室结果和死亡率。结果:148例患者中,108例(72.9%)患者接受了NOM治疗,40例(27.1%)患者接受了手术。根据修订创伤损伤量表、损伤严重程度评分和格拉斯哥昏迷量表,接受NOM治疗的患者严重损伤明显减少。手术组肝损伤程度、CT造影剂外渗及腹腔积血数量均高于手术组。两组患者入院时和入院后4小时心率、呼吸频率、收缩压、平均血红蛋白水平均有显著差异。手术组的死亡率明显高于NOM组。结论:我们的研究结果提示,在决定肝损伤的治疗时应考虑血流动力学稳定性和以下因素:肝损伤等级、出血量和损伤量表评分。
{"title":"Comparison between operative versus non-operative management of traumatic liver injury.","authors":"Ki Bum Park,&nbsp;Dong Do You,&nbsp;Tae Ho Hong,&nbsp;Jung Min Heo,&nbsp;Yong Sung Won","doi":"10.14701/kjhbps.2015.19.3.103","DOIUrl":"https://doi.org/10.14701/kjhbps.2015.19.3.103","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>The aim of this study was to compare operative versus non-operative management of patients with liver injury and to ascertain the differences of the clinical features.</p><p><strong>Methods: </strong>From April 2000 to July 2012, 191 patients were admitted to Seoul St. Mary's Hospital and St. Vincent's Hospital for liver injuries. Of these, 148 patients were included in this study. All patients were diagnosed using computed tomography (CT). The liver injury was graded in accordance with the American Association for the Surgery of Trauma liver injury scoring scale. Patients were divided into two groups: those who underwent surgery and those treated with non-operative management (NOM). There was a comparison between these two groups concerning the clinical characteristics, grade of liver injury, hemodynamic stability, laboratory findings, and mortality.</p><p><strong>Results: </strong>According to the 148 patient records evaluated, 108 (72.9%) patients were treated with NOM, and 40 (27.1%) underwent surgery. Patients treated with NOM had significantly fewer severe injuries as rated using the Revised Traumatic Injury Scale, Injury Severity Score, and Glasgow Coma Scale. Grade of liver injury and number of patients with extravasation of contrast dye on CT and hemoperitoneum were higher in the operative group than in the NOM group. There were significant differences between the two groups for: heart rate, respiratory rate, systolic blood pressure, and mean hemoglobin levels at admission and after 4 hours. The operative group experienced a significantly higher mortality than the NOM group.</p><p><strong>Conclusions: </strong>The results of our study suggest that hemodynamic stability and the following should be considered for deciding the treatment for liver injuries: grade of liver injury, amount of blood loss, and injury scales scores.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"19 3","pages":"103-8"},"PeriodicalIF":0.0,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2015.19.3.103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34013919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Korean journal of hepato-biliary-pancreatic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1